Dr. Martin M. Goldstein, MD

Dr. Goldstein practices at Summit Medical Group - Berkley Heights Campus in Teaneck, New Jersey.

Dr. Goldstein's NPI, 1831162189, was assigned on February 8, 2006. Dr. Goldstein graduated from Rutgers Robert Wood Johnson Medical School in 1994. Dr. Goldstein holds New Jersey license 25MA07060200.

Dr. Goldstein's primary practice is Summit Medical Group - Berkley Heights Campus, at 222 Cedar Ln, Teaneck, NJ 07666 in Bergen County. The practice phone is (908) 273-4300.

Dr. Goldstein's primary practice is Summit Medical Group - Berkley Heights Campus in Teaneck, New Jersey. Dr. Goldstein is also affiliated with Holy Name Medical Center. The medical group on file is Summit Health. Dmand AI also links Dr. Goldstein to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldstein practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Goldstein's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Goldstein is board certified in urology by the American Board of Urology. Dmand AI has Dr. Goldstein's licenses on file in 2 states: New Jersey and New York.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney disease, kidney stone disease and pelvic prolapse among the conditions Dr. Goldstein treats.

CMS data shows 11,378 Medicare services from Dr. Goldstein across 41 procedure codes in 2024, for 1,118 Medicare patients. Medicare paid $422,450 for them.

CMS counts 1,118 Medicare patients who saw Dr. Goldstein in 2024. The largest group is 65 to 74, with 521 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goldstein's median patient age at 67, with 18% women.

In 2024, Dr. Goldstein wrote 4,749 Medicare Part D claims for 984 patients. 92% of them were for generic drugs. CMS names the drug for 4,615 of them, across 27 drugs with 11 or more claims each, at $355,003 in total drug cost. In 2023, CMS named 3,971 claims across 28 drugs.

Dr. Goldstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goldstein as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Goldstein, published from 2017 to 2023. The most frequent topics are Prostate-Specific Antigen and Prostatic Neoplasms. Dr. Goldstein has published most often in Investig Clin Urol. Dr. Goldstein's most frequent co-authors are Glen Gejerman, MD, Michael Phillip Esposito, MD and Martin B. Goldstein, DO.

CMS Open Payments shows 216 general payments to Dr. Goldstein from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Urogen Pharma, Inc. paid the most, $1,718.

Dmand AI lists 1 award for Dr. Goldstein, most recently CMS Stage 1 EHR in 2012.

Dr. Goldstein graduated from Rutgers Robert Wood Johnson Medical School in 1994.

Dr. Goldstein is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.